A program for the optimum design of pharmacokinetic, pharmacodynamic, drug metabolism and drug-drug interaction models

被引:7
|
作者
Graham, G
Gueorguieva, I
Dickens, K
机构
[1] Novartis Pharma AG, CH-4052 Basel, Switzerland
[2] Univ Manchester, Ctr Appl Pharmacokinet Res, Sch Pharm & Pharmaceut Sci, Manchester M13 9PL, Lancs, England
关键词
optimum design; pharmacokinetics; pharmacodynamics; drug metabolism; drug-drug interactions;
D O I
10.1016/j.cmpb.2005.02.005
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Planning any experiment includes issues such as how many samples are to be taken and their location given some predictor variable. Often a model is used to explain these data; hence including this formally in the design will be beneficial for any subsequent parameter estimation and modelling. A number of criteria for model oriented experiments, which maximise the information content of the collected data are available. In this paper we present a program, Optdes, to investigate the optimal design of pharmacokinetic, pharmacodynamic, drug metabolism and drug-drug interaction models. Using the developed software the location of either a predetermined number of design points (exact designs) or together with the proportion of samples at each point (continuous designs) can be determined. Local as well as Bayesian designs can be optimised by either D- or A-optimality criteria. Although often the optimal design cannot be applied for practical reasons, alternative designs can be readily evaluated. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:237 / 249
页数:13
相关论文
共 50 条
  • [1] Drug-Drug Interaction Studies With Oral Contraceptives: Pharmacokinetic/Pharmacodynamic and Study Design Considerations
    Sun, Haiying
    Sivasubramanian, Rama
    Vaidya, Soniya
    Barve, Avantika
    Jarugula, Venkateswar
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 : S49 - S62
  • [2] Pharmacokinetic and pharmacodynamic drug-drug interaction of Nomilin with atorvastatin in hyperlipidemic mice
    Ding, Yan
    Guan, Huida
    Yan, Yingxuan
    Chen, Yan
    Huang, Cheng
    [J]. HELIYON, 2023, 9 (11)
  • [3] Pharmacokinetic and pharmacodynamic drug-drug interaction assessment between pradigastat and digoxin or warfarin
    Yan, Jing-He
    Meyers, Dan
    Lee, Zachary
    Danis, Kate
    Neelakantham, Srikanth
    Majumdar, Tapan
    Rebello, Sam
    Sunkara, Gangadhar
    Chen, Jin
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (07): : 800 - 808
  • [4] Pharmacokinetic and Pharmacodynamic Evaluation of the Drug-Drug Interaction Between Isavuconazole and Warfarin in Healthy Subjects
    Desai, Amit
    Yamazaki, Takao
    Dietz, Albert J.
    Kowalski, Donna
    Lademacher, Christopher
    Pearlman, Helene
    Akhtar, Shahzad
    Townsend, Robert
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (01): : 86 - 92
  • [5] Pharmacokinetic and Pharmacodynamic Drug-Drug Interactions: Research Methods and Applications
    Sun, Lei
    Mi, Kun
    Hou, Yixuan
    Hui, Tianyi
    Zhang, Lan
    Tao, Yanfei
    Liu, Zhenli
    Huang, Lingli
    [J]. METABOLITES, 2023, 13 (08)
  • [6] PHARMACOKINETIC AND PHARMACODYNAMIC ASSESSMENTS FOR HORMONAL CONTRACEPTIVE DRUG-DRUG INTERACTIONS
    Kim, N.
    Li, L.
    Kim, M.
    Davis, D.
    Huang, S. -M.
    Zhang, L.
    Zhao, P.
    Soule, L.
    Willett, G.
    Yu, C.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S20 - S20
  • [8] Drug-Drug Interaction Between Oxycodone and Diazepam by a Combined in Silico Pharmacokinetic and Pharmacodynamic Modeling Approach
    Ji, Beihong
    Xue, Ying
    Xu, Yuanyuan
    Liu, Shuhan
    Gough, Albert H.
    Xie, Xiang-Qun
    Wang, Junmei
    [J]. ACS CHEMICAL NEUROSCIENCE, 2021, 12 (10): : 1777 - 1790
  • [9] Pharmacodynamic Drug-Drug Interactions
    Niu, Jin
    Straubinger, Robert M.
    Mager, Donald E.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (06) : 1395 - 1406
  • [10] Pharmacokinetic and Pharmacodynamic Analyses of Drug-Drug Interactions between Iguratimod and Warfarin
    Yamamoto, Tetsuya
    Hasegawa, Kyoko
    Onoda, Makoto
    Tanaka, Keiichi
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2016, 136 (06): : 905 - 911